Original Scientific Papers

At the MIND Foundation, we believe in the principles of Open Science (see Unesco page on Open Science) and aim to make knowledge available and accessible to everyone.

One of our initiatives in that matter was to obtain a license from the science publishing house Thieme Verlag to translate and make available all article from the 2021 special issue of Pharmacopsychiatry on Psychedelics in Psychiatry. The four articles from the journal will successively be made available here.

Given MIND’s limited resources, this is only possible with the support of committed volunteer-translators and -reviewers. We are deeply indebted to their generous help.

Please find below the first set of German translations:

MIND BLOG

Perspective
Clinical Psychology
Insights Into the Inaugural Year of APT — a New Training for Becoming a Psychedelic Therapist

MIND Foundation’s Augmented Psychotherapy Training (APT) is a 2-year professional development program that teaches the skills needed for psychedelic therapy.

Steph Lee, M.A.
•
October 12, 2022
Essay
Drug Science
The Synthetic Toad – How To Investigate 5-MeO-DMT in the Lab

The psychedelic drug 5-MeO-DMT is found naturally in the venom of the Sonoran Desert toad. Promising findings from field and early clinical research suggest that the substance may have therapeutic value as a rapid antidepressant.

Johannes Reckweg, M.Sc.Dr. Lukas Basedow
•
July 28, 2022
Essay
Consciousness Research
Merging Biology and Psychotherapy Within Psychiatry: An Interview with Collin Reiff, MD

Psychiatry has fluctuated between biology and psychotherapy throughout its history. Where are we now, and what impact might psychedelics have on the field?

Collin Reiff, MDSaga Briggs
•
May 13, 2022

MIND Foundation Newsletter

Sign up for our newsletter and we’ll keep you up to date with everything to do with the MIND Foundation.